U.S. Entertainment Stock News

Repligen Corporation recently reported its fourth-quarter and full-year 2025 results, with revenue rising to US$197.91 million for the quarter and US$738.26 million for the year, alongside a shift from loss to net income and positive earnings per share. However, despite these stronger headline earnings, multiple recent analyses have highlighted concerns about Repligen’s declining operating margins, reduced return on invested capital, and the constraints of its modest scale within the...

Why Kohl's earnings date is back in focus Kohl's (KSS) is back on traders' radar ahead of its fourth quarter earnings on March 10, with the stock historically showing large single day moves around these reports. Wall Street is looking for earnings of $0.85 per share and revenue of $5.23b, both expected to be lower than the same quarter a year ago. Recent estimate tweaks and high short interest are setting the stage for an active reaction to the actual numbers. See our latest analysis for...

In late February 2026, Omnicom Group completed several US$-denominated senior fixed-rate note offerings totaling about US$1.70 billion across 2029, 2033, and 2036 maturities, featuring callable, senior, unsecured structures with fixed coupons around 4.2%–5.3% and modest original issue discounts. These bond issuances, alongside Omnicom’s recent Interpublic integration progress and upgrades to its Omni data and technology platform, highlight the company’s focus on funding flexibility while it...

Earlier this week, Acuity Brands, a provider of intelligent lighting and space solutions, was caught up in market volatility as rising Middle East tensions pushed crude oil prices higher, heightening concerns about broader inflation and possible pressure on corporate costs and demand. While there was no change to Acuity’s operations or fundamentals, the episode underlined how external energy and inflation shocks can quickly influence investor sentiment around even relatively stable...

If you are wondering whether Archer-Daniels-Midland is still reasonably priced after a strong run, you are not alone. This article will focus squarely on what you might be paying for at today's share price. The stock last closed at US$67.44, with a 7 day return of a 2.3% decline, roughly flat over 30 days at 0.1%, up 14.2% year to date and 41.2% over the past year, compared with a 2.9% decline over 3 years and a 33.2% gain over 5 years. Recent news coverage around Archer-Daniels-Midland has...

Why Supernus Pharmaceuticals Stock Is On Investors’ Radar This Week Supernus Pharmaceuticals (SUPN) has drawn fresh attention after releasing fourth quarter and full year 2025 results alongside new 2026 guidance that pairs higher revenue expectations with a relatively modest operating earnings range. See our latest analysis for Supernus Pharmaceuticals. Those 2025 results and the fresh 2026 guidance arrived after a strong 12 months for investors, with a 1 year total shareholder return of...

Transocean (RIG) is back in focus after its recent quarterly update, which showed stronger contract activity, a larger offshore drilling backlog, reduced debt and Q1 revenue guidance that came in ahead of earlier expectations. See our latest analysis for Transocean. Despite a softer 1 day share price return of a 3.26% decline and a 7 day share price return of an 8.49% decline, Transocean’s recent operational updates sit against a much stronger backdrop, with a 30 day share price return of...

Ring Energy (REI) is back in focus after reporting a net loss for both the fourth quarter and full year 2025, along with a large impairment charge and a reset in finance leadership. See our latest analysis for Ring Energy. Despite the recent earnings loss and finance leadership changes, Ring Energy's share price has shown strong momentum, with a 63.7% 3 month share price return and a 70.1% year to date share price return. However, the 5 year total shareholder return of 48.0% signals a weaker...

If you are wondering whether Biglari Holdings at around US$1,678.97 is still offering value or has already priced in its appeal, you are not alone. The stock has seen a 15.6% decline over the last 7 days and an 18.4% decline over the last 30 days, while its 1 year and 5 year returns of 59.0% and 117.1% hint at a very different longer term picture. These moves have come alongside ongoing investor interest in how Biglari Holdings allocates capital across its diverse operations and investments,...

What Cousins Properties’ Recent Share Performance Tells You Cousins Properties (CUZ) has drawn fresh attention after a mixed stretch in the stock, with a 2.3% decline over the past day, a small gain over the past week, and weaker returns over the past month and past 3 months. See our latest analysis for Cousins Properties. Looking beyond the latest 1-day share price return of 2.27% and recent 30-day and year to date share price declines of around 10%, Cousins Properties’ 3-year total...

In the past quarter, Moelis & Company reported fourth-quarter 2025 adjusted earnings of US$1.13 per share, with total revenues rising 11% year over year while higher compensation and non-compensation expenses lifted overall operating costs. The firm also repurchased 700,000 shares during the period, highlighting an active approach to capital allocation even as expenses increased. Next, we’ll examine how Moelis’s better‑than‑expected earnings and revenue, alongside rising operating costs,...

What recent performance says about Powell Industries today Powell Industries (POWL) has drawn fresh attention after a strong past 3 months, with total return around 41%, following a much larger 1 year total return near 198%. For investors looking at the current setup, the stock last closed at US$483.65, with value metrics that some data providers group into a relatively low value score of 2. See our latest analysis for Powell Industries. That recent pullback in the share price, with a 7 day...

In recent weeks, Wynn Resorts has been closely monitoring escalating Middle East tensions after Iranian strikes near Dubai, where it is helping develop the US$5.10 billion Wynn Al Marjan Island resort in the UAE, while rolling out contingency measures to protect project staff and confirm the property’s planned 2027 opening. At the same time, Wynn has advanced its broader growth plans and brand positioning, from deepening its premium UAE commitment to launching an exclusive Zero Bond members’...

Addus HomeCare (ADUS) has drawn fresh attention after reporting fourth quarter net income of US$29.78 million and full year net income of US$95.91 million, together with higher diluted earnings per share from continuing operations. See our latest analysis for Addus HomeCare. Despite the stronger earnings story, recent share price momentum has been soft. The 90 day share price return shows an 8.82% decline, contrasting with a 1 year total shareholder return of 6.37%, suggesting interest has...

Plains All American Pipeline (NasdaqGS:PAA) reported a new definitive agreement in a recent SEC Form 8-K filing. The company also disclosed amendments to existing credit agreements with a group of major lenders. These updates relate to Plains All American Pipeline's financing structure and contractual commitments. Plains All American Pipeline focuses on the transportation, storage, and marketing of crude oil and related products, which ties its business closely to broader midstream energy...

Novavax, Inc. recently reported fourth-quarter 2025 revenue of US$147.14 million and net income of US$17.53 million, alongside full-year 2025 revenue of US$1.12 billion and net income of US$440.30 million, marking a move from losses to profits versus the prior year. The shift from a prior-year full-year net loss of US$187.50 million to net income of US$440.30 million highlights how higher vaccine-related revenues and cost discipline have materially changed Novavax’s recent financial...

If you are wondering whether KeyCorp is attractively priced or already fully valued, you are not alone. This article is designed to help you make sense of where it stands today. KeyCorp shares last closed at US$19.86, with returns of a 4.2% decline over 7 days, a 12.3% decline over 30 days, a 5.3% decline year to date, but a 32% gain over 1 year, 49.6% over 3 years and 18.7% over 5 years. This gives a mixed picture for investors assessing recent momentum. Recent headlines around KeyCorp have...

Why Centessa Pharmaceuticals Stock Is Back in Focus Centessa Pharmaceuticals (CNTA) has hit an early development milestone for its investigational orexin receptor 2 agonist, ORX489, tied to neuropsychiatric disorders. This achievement has triggered a US$3 million milestone payment to collaboration partner Nxera Pharma. The payment is set to be recognized as revenue in the first quarter of 2026, giving investors a fresh data point on how this research collaboration feeds into Centessa's...

DiamondRock Hospitality Company recently reported its fourth-quarter and full-year 2025 results, showing higher net income and earnings per share despite slightly lower sales and revenue, while also updating investors on its ongoing share repurchase program and a quarterly dividend of US$0.09 per share payable in April 2026. The combination of improved profitability, continued capital returns through buybacks and dividends, and upcoming board leadership changes adds new context for how...

Law firm launches investigation into NYSE:NVO for potential securities violations following a setback in an obesity drug clinical trial. U.S. regulators issue warning letters to telehealth companies selling compounded GLP-1 drugs that compete with Novo Nordisk’s branded treatments. Developments raise questions about legal exposure for the company and the regulatory environment around GLP-1 weight loss therapies. As a leader in GLP-1 based therapies for diabetes and obesity, NYSE:NVO sits at...

Revolution Medicines (NasdaqGS:RVMD) is advancing clinical trials for its RAS(ON) inhibitor pipeline targeting RAS-addicted cancers. The company reported higher R&D spending and wider net losses as it pushes its oncology candidates through the clinic. To reinforce its balance sheet, RVMD filed for a US$1b at-the-market equity program and a US$1.24b shelf registration. Director Mark A. Goldsmith reported significant insider share sales, drawing attention to executive capital...

Earnings jump puts China Yuchai International (CYD) in focus China Yuchai International (NYSE:CYD) is back on investor radars after reporting full year 2025 results, with sales of CN¥24,661.77 million and net income of CN¥537.39 million compared to the prior year. See our latest analysis for China Yuchai International. The latest earnings release has arrived after a strong period for investors, with the share price at US$41.30, a 90 day share price return of 18.85% and a 1 year total...

AGNC Investment stock moves and recent performance snapshot AGNC Investment (AGNC) has drawn investor attention after a recent pullback, with the stock closing at US$10.64 and showing mixed total returns across the past week, month, past 3 months and year. See our latest analysis for AGNC Investment. The recent pullback, including a 2.39% one day share price decline and softer 7 day and 30 day share price returns, sits alongside a 12 month total shareholder return of 18.48% and a 3 year total...

Recent analyst moves around UDR (UDR), including several rating reiterations and revised views, have put the apartment REIT back on investors’ radar, with opinions split on near term demand but generally constructive on its dividend track record. See our latest analysis for UDR. UDR’s share price has been fairly range bound recently, with a 1 day share price return of 1.11% decline and a 90 day share price return of 5.82% lifting it modestly year to date. However, the 1 year total shareholder...